GPR30: a novel therapeutic target in estrogen-related disease.
about
Botanical modulation of menopausal symptoms: mechanisms of action?Estrogen and progesterone receptors: from molecular structures to clinical targetsEstrogen biology: new insights into GPER function and clinical opportunitiesContributions of academic laboratories to the discovery and development of chemical biology toolsExogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptorsEstrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30Mitogen-Activated Protein Kinase 8 (MAP3K8) Mediates the Signaling Pathway of Estradiol Stimulating Progesterone Production Through G Protein-Coupled Receptor 30 (GPR30) in Mouse Corpus Luteum.Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.Mechanisms of estrogen signaling and gene expression via GPR30Reproductive aging, sex steroids, and mood disordersIn vivo effects of a GPR30 antagonistHigh expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinomaGPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.GPR30 predicts poor survival for ovarian cancerImprovement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus.Estrogen receptor ligands: a patent review update.Is oestrogen an important player in melanoma progression?Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implicationsEstrogen action and prostate cancer.Estrogen-induced plasticity from cells to circuits: predictions for cognitive function.G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityG protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells.MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.Rapid behavioural effects of oestrogens and fast regulation of their local synthesis by brain aromatase.Rapid regulation of brain oestrogen synthesis: the behavioural roles of oestrogens and their fates.ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.G protein-coupled estrogen receptor inhibits the P2Y receptor-mediated Ca(2+) signaling pathway in human airway epithelia.Estrogen-dependent enhancement of NO production in the nucleus tractus solitarius contributes to ethanol-induced hypotension in conscious female rats.Sex differences and hormonal modulation of deep tissue pain.New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.Estrogen receptors and function in the male reproductive system.G protein-coupled receptor 30 in tumor development.Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.Combating malaria with plant molecules: a brief update.Gender and cataract--the role of estrogen.
P2860
Q24607818-C99B201A-F9B7-47C5-BBCD-EEA81F83E37EQ28239860-3DF12CC7-3033-4761-A575-A7BD321F8652Q28307726-24A6FFB4-76E6-4F9C-84D9-3A1B5A9F29D2Q28389188-FEFAB2D6-E8B6-4A84-A1F0-2B405A5215BBQ28393495-F3D1E9B2-1275-4E55-95F0-98AD20F88B7BQ30478476-9C66E3BC-6C96-49F9-80A3-8E430B2C5F88Q33508904-ECCAAE4F-5D83-4D72-9CE8-276B12AED9A3Q33631714-9D63BDD1-7ABE-4045-96AA-A28900F82271Q33640444-4D85C95A-3F06-4470-9B86-E36F95D391DDQ33760458-07B1B20B-6000-4723-B4B4-7839F8D8C1EBQ33820067-58B991CD-836E-41A6-84B2-39F70CBBBCBAQ33828472-F5E7BAEA-BB1A-425B-BBF0-BDC14C75CCFCQ33898496-D906AAA7-6732-4F70-A5B3-69B6E6410341Q33996321-5B085C1E-565A-4C27-8EA7-285F5B447B3AQ34066297-BC2694B3-B641-4D49-9E9E-97BFD27DEBA4Q34297149-BBF8ACA2-F1C9-4AC0-A385-786D36258332Q34347152-8B73B383-C4F4-413B-AB17-E964040A7DA4Q34589095-CEDD7773-B72E-49B6-8984-DAAF8E836477Q34827433-46516E76-A3F3-46B6-96A1-70A3DC68A702Q35099011-A55060A1-8FBF-476B-BC17-D39F39BB8953Q35197869-C51490C5-1590-4962-904A-033DCBCDBDC1Q35435464-A4FE1EE6-DD16-4B07-942A-232917C96E9CQ35543617-C5102929-849E-41D4-BF15-DBB93DB5833EQ35563456-B0152238-935A-43D5-9558-AB9E62DADE89Q36036783-D7951017-9627-49A8-AE10-4CEF737D8756Q36290327-47B24F37-C315-48E4-851B-6E267FBE35E1Q36457556-58A41ADC-B125-4F7F-9E0E-A684B759BE57Q36457600-37CA6CCC-29B0-478C-A224-535E49CD200BQ36666948-F1500E31-960A-4CB1-A57C-D0E5349481F4Q37069818-0A8721F7-9D4B-4ACC-AE5A-E1D47C2E292AQ37084906-44BE6C3C-F258-4792-8A26-4D9ACCDD962EQ37110316-02F7F5EC-0791-4601-A00B-91DB5E16E6FBQ37153958-50FCB4C2-5333-47A9-B46C-39811AA58766Q37315036-56D45D06-E28B-478F-8CD3-93535250B9C2Q37374183-0C5EF295-EB6F-4655-95D3-98C0A8AAD2FCQ37686148-3DA2FFFD-F42B-43A6-A544-A65C61AAED26Q37801571-FFC8A2E7-9B55-495D-B4A5-3A9C563FA226Q38117062-82751544-32AB-41B0-99B8-C23DAF3B6734Q38155893-393938FC-6E57-47B3-965B-1FF8201DB5C9Q38225583-C06A75E0-6DF1-431F-AEE8-783D399E1874
P2860
GPR30: a novel therapeutic target in estrogen-related disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
GPR30: a novel therapeutic target in estrogen-related disease.
@en
GPR30: a novel therapeutic target in estrogen-related disease.
@nl
type
label
GPR30: a novel therapeutic target in estrogen-related disease.
@en
GPR30: a novel therapeutic target in estrogen-related disease.
@nl
prefLabel
GPR30: a novel therapeutic target in estrogen-related disease.
@en
GPR30: a novel therapeutic target in estrogen-related disease.
@nl
P1476
GPR30: a novel therapeutic target in estrogen-related disease.
@en
P2093
Jeffrey B Arterburn
Larry A Sklar
P304
P356
10.1016/J.TIPS.2008.01.001
P577
2008-02-11T00:00:00Z